ProfileGDS5822 / ILMN_1229933
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 62% 46% 11% 37% 41% 8% 38% 49% 30% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 130.862
GSM1276600PDAC Late Ablation Control 222.346
GSM1276601PDAC Late Ablation Control 33.711
GSM1276602PDAC Late Ablation 115.137
GSM1276603PDAC Late Ablation 21941
GSM1276604PDAC Late Ablation 37.48
GSM1303940PDAC Late Ablation_anti-CTLA4 117.938
GSM1303941PDAC Late Ablation_anti-CTLA4 224.449
GSM1303942PDAC Late Ablation_anti-CTLA4 314.730